Tenet Healthcare (THC) – Analysts’ Weekly Ratings Updates

Tenet Healthcare (NYSE: THC) recently received a number of ratings updates from brokerages and research firms:

• 10/17/2025 – Tenet Healthcare had its price target raised by analysts at Mizuho from $194.00 to $225.00. They now have an “outperform” rating on the stock.
• 10/14/2025 – Tenet Healthcare was given a new $225.00 price target on by analysts at Truist Financial Corporation.
• 10/14/2025 – Tenet Healthcare is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “buy” rating and a $224.00 price target on the stock.
• 10/14/2025 – Tenet Healthcare is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “buy” rating and a $224.00 price target on the stock.
• 10/8/2025 – Tenet Healthcare had its price target raised by analysts at KeyCorp from $205.00 to $225.00. They now have an “overweight” rating on the stock.
• 10/8/2025 – Tenet Healthcare had its “hold (c+)” rating reaffirmed by analysts at Weiss Ratings.
• 10/7/2025 – Tenet Healthcare had its price target raised by analysts at Wells Fargo & Company from $200.00 to $238.00. They now have an “overweight” rating on the stock.
• 10/7/2025 – Tenet Healthcare had its “overweight” rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $190.00 price target on the stock.
• 10/6/2025 – Tenet Healthcare was downgraded by analysts at Zacks Research from a “strong-buy” rating to a “hold” rating.
• 9/27/2025 – Tenet Healthcare had its “hold (c+)” rating reaffirmed by analysts at Weiss Ratings.
• 9/18/2025 – Tenet Healthcare had its price target raised by analysts at Barclays PLC from $208.00 to $229.00. They now have an “overweight” rating on the stock.
• 9/10/2025 – Tenet Healthcare had its price target raised by analysts at Bank of America Corporation from $205.00 to $225.00. They now have a “buy” rating on the stock.
• 8/26/2025 – Tenet Healthcare had its “overweight” rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $190.00 price target on the stock.

Insider Buying and Selling

In related news, EVP Lisa Y. Foo sold 8,000 shares of the firm’s stock in a transaction that occurred on Wednesday, August 20th. The stock was sold at an average price of $179.53, for a total transaction of $1,436,240.00. Following the completion of the transaction, the executive vice president owned 20,878 shares in the company, valued at $3,748,227.34. This trade represents a 27.70% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Saumya Sutaria sold 78,762 shares of the firm’s stock in a transaction that occurred on Wednesday, September 10th. The stock was sold at an average price of $190.78, for a total value of $15,026,214.36. Following the transaction, the chief executive officer owned 368,683 shares of the company’s stock, valued at $70,337,342.74. This trade represents a 17.60% decrease in their position. The disclosure for this sale can be found here. Insiders sold 90,722 shares of company stock worth $17,161,015 in the last 90 days. 0.81% of the stock is owned by company insiders.

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.